Form 4: GoodRx Holdings Chief Accounting Officer Reports Stock Transactions

Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reported the acquisition and disposal of Class A common stock and restricted stock units on December 8, 2024.

Summary

• Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, engaged in multiple transactions involving the company's Class A common stock and restricted stock units on December 8, 2024.
• These transactions included the acquisition of 10,200 shares and 2,232 shares of Class A common stock through the vesting of restricted stock units.
• Additionally, 3,640 shares and 797 shares of Class A common stock were disposed of to cover tax obligations related to the vesting of the restricted stock units.
• Following these transactions, Mr. Nabiey beneficially owns 90,444 shares of Class A common stock and 29,020 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by a company officer, which is neither positive nor negative in itself.

Industry Context

This filing is a routine disclosure of stock transactions by a company officer, which is common practice for publicly traded companies.

Comparison to Industry Standards

• The reporting of stock transactions by company officers is a standard practice across all publicly listed companies in the US.
• The use of restricted stock units as part of executive compensation is also a common practice.
• The vesting schedules described are typical for such awards, with quarterly vesting over a period of several years.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to the vesting of previously granted stock options and tax obligations of a company officer.

Key Dates

Keywords

GoodRx Holdings, GDRX, Romin Nabiey, Chief Accounting Officer, Class A Common Stock, Restricted Stock Units, Stock Transactions, SEC Form 4, Beneficial Ownership